Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The thing with Huw is that he could make out a clapped out old Datsun Sunny is a vintage sports car. Everything is brilliant with EVG, even when Juvenesense pulled out he made it a positive that EVG were looking for more lucrative deals than that. Yet a few weeks earlier EVG were saying such positive things about that partnership.
I’m starting to think Huw maybe xxPoorInvestorxx as they both always ramp everything and make out things are very exciting.
But should I tell you what I really like about xxPoorInvestorxx?
I do think existing shareholders should start to consider ousting Huw during the next AGM. He has proved to be completely out of his depth, blatantly lying and ramping up the share price just before a share placement announcement.
DS, I remember you saying back in late 2022 that you bought a million shares in EVG. Do you still hold a million shares in this? If so what sort of paper loss are you showing and how do you feel about your investment? I mean you must be frustrated by how it’s going?
I bought in at an average of 4.7p and sold out at 2.55p. It has been the right move. I don’t personally see any reason to buy back in unless a lot of clarification happens on guaranteed future payments (and not just pie in the sky statements) and new contracts signed.
Yep, sadly it has not been a good year or so for EVG. Very little communication from EVG as well. Big year for EVG, should answer a lot of questions this year whether it’s got a future or not.
What a mess this has turned into.
I see PoorInvestor and his Merry men got excited that incoming news was due after seeing a flurry of transactions.
Is there incoming news? Not on your Nelly. No chance. No way Jose. This is EVG, don’t expect any significant updates for months.
As for PoorInvestor who had stayed awake wondering if a buy out of EVG is on the cards? No chance. No way Jose. Who the heck would buy this out at this stage? It’s burning through money faster than Boris Becker.
Toni could be one of the catalysts Evgen need. Faron has an mcap of £200M which may or may not have something to do with it's Nasdaq First North listing..
Obviously only me speculating but if he can bring in some new initiatives like additional listings to help trading volume, market awareness whilst improving the sp he's got my vote.
Nasdaq First North: https://www.nasdaq.com/solutions/listings/markets/nordics/first-north
Funny how some on here view Toni as some kind of saviour, I personally think he is just another drain on a shrinking reserve. The company has way to many directors who all hold second or third jobs being paid a full time salary it's scandalous.
Why is Huw still at the helm, having presided over a 90% share decline he is somewhat fortunate to still have a job, in any other job with proper checks and balances he would have been long gone.
Perhaps Toni has plans to take Evgen to Nasdaq, he has expertise....
"Toni was previously CFO at Faron Pharmaceuticals Ltd, an AIM and Nasdaq First North listed clinical stage biopharmaceutical company based in the Finland and the US, developing novel treatments for medical conditions with significant unmet needs"
Firefly merging with Wavedancer this month acquiring a large sales team in the US but not much else in the deal and obtaining a Nasdaq listing is something that I keep coming back to.
Their nuro database, a sales team and Nasdaq listing seems to lack one thing imo...
Could Firefly be getting into Evgen with a view to taking our product into the USA...
I Can't see any reason why they wouldn't 'assuming' our product looks like a possible treatment for ASD and maybe other neurological disorders.
Nasdaq here we come lol would be an amazing turn of events and this is only a chat board so why not bounce some scenarios around 😃
In fairness to CJ39 and where you are slightly bending the information out there to your own angle
"Did Evgen receive ‘up to $6m’ in 2023? Yes, Evgen received $500k from Stalicla"
The 500k wasn't part of that $6m and that was made perfectly clear in the RNS.
It's nice to see a slight pick up in the price, the cynic in me thinks the MM have a massive overhang in stock from the AXA sale and are artificially trying to generate a false dawn to attract more buyers, or it could just be part of a re rating of the whole sector.
Pro I would like your thoughts on when you think Evgen will undertake a new placement and how much they are likely to raise.
Going by the last cash call, they raised funds around 9 months prior to when the cash was due to run out, it would be somewhat suicidal not to bother at all in the hope that Stalicla come through.
They could always borrow the money I suppose which would protect shareholders value but at what cost.
We are all pretty much in agreement that if Stalicla doesn't come through with the funds a cash call is inevitable, Pro how much do you think they'll have to raise in such a scenario, £10m was the last call.
One thing is for certain and why my trust in the bods is so low, prior to any announcement there will be a flurry of positive news promising the earth to ramp the price up.
Huw was in overdrive with positive announcements just prior to the last cash call, that together with his track record when it comes to failed companies doesn't feel me with confidence and why I'm so passionate about making sure that other non suspecting punters don't fall into the same trap.
Of course, it would have been nice to have a more in-depth answer on why Juvensesence decided to change direction and I am sure Evg would have communicated this if they had known. Any reasoning here would be pure speculation, however, since it was not just SFX-01 that they dropped, it is fair to assume that it had nothing to do with SFX-01, otherwise I’m sure they would have communicated this with Evgen.
Really? Do you not understand what ‘up to’ means?
From the Cambridge dictionary: Up to - used to say that something is less than or equal to but not more than a stated value, number, or level: Up to two hundred people were on board the ship.
Did Evgen receive ‘up to $6m’ in 2023? Yes, Evgen received $500k from Stalicla in 2023 and one would define this as ‘up to $6m’. Could they have written it in a more unambiguous way? Sure, they could have added ‘expected’ or similar wording but did they lie? No. Writing ‘up to’ indicates that the entire sum is not guaranteed and has the same effect as writing 'expected'.
You fail to grasp my point on the share placement entirely. Of course, if one would be carried out now, then it would likely be at a discount to the current share price, I have never suggested otherwise. It is the notion that they would attempt to raise such a large amount of cash, at such a low share price and shareholder would accept this. They would not.
The bod only have authority to raise funds from the placement of circa 90m new shares (up to an aggregate nominal amount of £229,073). Any more than this, and they require shareholders' approval at an EGM. Do you really believe shareholders would approve the issuing of over 600m new shares with the share price hovering at all-time lows, while the economic backdrop is so poor unless it was vital for the immediate survival of the company?
Many aim companies raise fund yearly, or even multiple times a year, Evgen did so prior to the large placement in 2021, and imo would likely go back to doing so with the share price so low.
As I have stated before, the only way I would see a raise being proposed in 2024 by the bod would be if one of the below scenarios played out:
1. Stalicla milestone payments delayed into late24/2025
2. Stailicla abandoning SFX-01
3. As part of a separate out-licencing deal for another target indication (cancer?) at the request of the partner to ensure sufficient cash runway
4. If during the course of this year the share price see a significant uplift
5. If there is interest to take a stake at a large premium to the prevailing share price
Situations 1 and 2 would be devastating for shareholders. However, depending on the environment, carrying out a raise as a result of situations 3-5 could be in the best interest of shareholders.
This is what I don't get with you, you say I talk nonsense and lack of further analysis from myself and kingalf, yet you have demonstrated this is exactly what you do, not me.
The Juv deal, I am totally aware that EVG and Juvenescense said that it was a change in business direction. So you think that is fine, that explains all and if only I had read that it would explain everything I needed to know? Really? I said I wanted to know why after 3 years of Juvenescense working on product development and spending a lot of money they decided to return the rights. There must have been a reason why they did that and that was what I wanted to know. Was it that the SFX-01 product was not showing the results they wanted? Did they feel the product would not be profitable? Why did they not include this venture in their new business direction? But of course me wanting to know further details is according to you me talking nonsense and lack of detail and analysis from me? Interesting.
As for the Stalicla delay, you say I fail to understand the complexities of pharma research. Well that's brilliant thank you for explaining. I mean my goodness, you fail to understand a simple point I made. The point I made was that EVG originally wrote - and I quote in the Half Year Report 08/12/2022 'Up to $6m in initial milestones to be received before end of 2023' changed to 'Up to $5.5m in further milestones expected within 2024' in the Final Results 07/06/2023. My point here is why did EVG write $6m to be received before end of 2023 if it was not set in stone? Why did they not write $6m anticipated or expected before end of 2023? You seem to think it is perfectly acceptable to claim something will be received by a certain date and then if it is does not happen then it is fine because it is complex. Look, don't say it if it is not guaranteed.
You seem to like being condescending in that I lost £3200 here saying it is a little amount and it surely is a small fraction of my portfolio. Maybe £3200 isn't much to you, maybe you are loaded and £3200 isn't anything to be bothered by. I invested here hoping to double my money. Yes I could afford to lose it but it was never my aim to lose £3200, I would have used that to go dining out at nice restaurants every friday for a year or go on a second holiday last year.
Share placing - I agree with Alf, if there is a share placing it will of course be between 1p and 1.5p given what the current share price is. What do you think a share placing will be at? Whether it happens we will see but even you cannot deny the fact that money is running out and without the Stalicla money they will need to issue a share placing in order to raise money to keep the company afloat.
I am critical of the nonsense being posted not the fact that the comments are negative. I have no issue if the negative comments have merit and logical reasoning behind them. Comments about the lack of communication from the Evg board, Huw not demonstrating prowess as a CEO, bod not buying shares, frustrations around the Juv deal and delays I agree with in part, or entirely.
But context and further analysis is often lacking from yourself and Kingalf. A few examples below.
1. Juv deal - if you cared to explore further you would have been able to discover that the bod did give a reason for the partnership ending and their reasoning could be confirmed by looking at the Juv website which clearly displayed the companies change of direction.
2. Stalicla delay - While the delay is frustrating and not ideal, you fail to understand the complexities of pharmaceutical research and that delays are an unfortunate reality in many industries. You are then suggesting that the bod of Evgen are committing fraud by lying to investors about their expectations and that IND will not happen this year, without any reason why.
3. AXA - Claiming AXA have insider knowledge of a placement and so are selling out, even though this would be illegal.
4. Share placement - Kingalf was trying to elude to the fact that the company will make a placement for £10m at 1.5p and dilute shareholder over 70%. Simple critical thinking would enable any reasonable person to conclude that this is nonsensical. Why would shareholders approve such a large placement, at such a low share price, if it was not absolutely necessary for the companies survival? They would not. A placement could happen, but nothing like is being suggested by derampers.
This doesn't include the nonsense spewed about how SFX-01 cannot work because it is found in broccoli and that it could therefore never be used to treat autism, or that another company could manufacture their own version, or how sulforaphane can be found on Amazon and is comparable to SFX-01, or how you guys invested because Kight did, without doing any due diligence.
The list of false lies and rubbish posed by the deramping crew here goes on and on. The fact is, you guys are emotionally damaged by your losses from Evgen, and now you're trying your hardest to prove that your judgement in the end was correct. You're resorting to lies and misinformation to push the share price down to make yourself feel better.
So let me get this straight you post on Music Magpie messageboard but you are not invested there? But you are critical of people who post on this EVG messageboard who were invested and sold out? So posting on a messageboard when not invested is ok if you do it but not for others?
I have also been wondering if a buyout was on the cards. We know that once Stalicla apply for, and get approval of, the IND for SPT2 from the FDA, they will need to pay Evgen $5m. They then will have an additional $154m milestone payments as well as royalties to pay if SPT2 reaches commercialisation. How much would Stalicla need to pay to acquire the entire company? And surely with the share price so low, buying Evgen would prove to be the cheaper option long term.
The question is, how much would someone pay for Evgen?
This is actually the highest volume day for over a year, in fact since the week the Stalicla deal was announced believe it or not, and its only 11:30am.
Quite a few biotechs up today so could just be a feelgood for the whole sector in 2024.
Obviously we are due news but I wouldn't be surprised to see someone snap up Evgen with the Stalicla deal and other RNS's regards Cancers we had last year...
My guess would be Firefly Neuroscience taking an interest on the back of the Wavedancer Merger due to complete this month and their tyeup with Stalicla...
Just imo and could be completely wrong.
Unusual buying today for sure
Good momentum and lets hope this is the start of the re-rate. News is the only think that will sustain this rise though.
CJ,
Again with immature name change all you are doing is proving me correct, so thank you. Clearly I have rattled you as you are hurling even more abuse. I am only dismissive of comments that have no foundational basis and are complete nonsense.
If you had actually looked at the comments I have posted on Mmag, then you would have seen that I am not invested there. This lack of basic analysis or further research and due diligence on your behalf sums up the lack of thought you put into your investments and why you are so sore about losing a paltry sum on Evgen.
Investing in two big shares does not mean you are clued up at all. You have demonstrated your lack of intelligence and naivety many times on this board.
Yes, there is a chance I am wrong here, and I won’t mind admitting it if that comes to fruition, however, can the same be said for you? Probably not.
Interesting but where is the science news?
Want to see an RNS before investing in Brocoli.
The share had gone up by 26% the Share Price is up 0.4p !!!!!! but you never know could be 40% soon.
Make that 40% at 10.44 am
Share price currently up 30% at 10.43 am.